Filing Details

Accession Number:
0000899243-23-020350
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-14 19:08:54
Reporting Period:
2023-11-14
Accepted Time:
2023-11-14 19:08:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1966494 Cargo Therapeutics Inc. CRGX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1778071 Third Rock Ventures V, L.p. C/O Third Rock Ventures, Llc
201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1931056 Third Rock Ventures Vi, L.p. 201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1977498 Third Rock Ventures Gp V, Lp 201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1977499 Third Rock Ventures Gp Vi, L.p. 201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1990716 Trv Gp Vi, Llc 201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1990717 Trv Gp V, Llc 201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-14 1,737,216 $0.00 1,737,216 No 4 C Direct
Common Stock Acquisiton 2023-11-14 473,786 $0.00 473,786 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2023-11-14 1,333,333 $15.00 1,807,119 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Indirect See Footnotes
No 4 P Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Preferred Stock Disposition 2023-11-14 23,571,429 $0.00 1,737,216 $0.00
Common Stock Series A-1 Preferred Stock Disposition 2023-11-14 6,428,571 $0.00 473,786 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. Represents the total number of shares of Common Stock received by Third Rock Ventures V, L.P. ("TRV V") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering.
  2. The Series A-1 Preferred Stock converted into Common Stock on a 13.5685-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-1 Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A-1 Preferred Stock had no expiration date.
  3. These shares are directly held by TRV V.
  4. The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  5. Represents the total number of shares of Common Stock received by Third Rock Ventures VI, L.P. ("TRV VI") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering.
  6. These shares are directly held by TRV VI.
  7. The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI and TRV GP VI LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  8. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between the TRV V related parties and the TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.